Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
Longevity Prediction Market

When will Anthropic's first clinical phase begin?

approved openMultiple choicePrognosis made 1 Jul 2026Voting closes 1 Nov 20260 traders0.00 cr volume

Chance it happens

71%
Happens 71%No 14%Other 14%

Belief the predicted event happens at all — every “yes / by-a-date” outcome added together. “Other” is tracked as its own third slice.

Outcomes

By end of 202714.3%
202814.3%
202914.3%
203014.3%
2031 or later14.3%
Never as an Anthropic program14.3%
Other14.3%

Resolution criteria

A candidate for which Anthropic is the originator or sponsor enters a registered Phase 1. Resolution horizon: 2031-12-31. Source: ClinicalTrials.gov.

Evidence & context

Trials, publications and reports our research found on this prognosis. Each links to the original source.

Anthropic

This is a social post linking to a CNBC news report that Anthropic is starting an internal drug discovery program. It is indirect but relevant evidence because it indicates Anthropic is moving toward therapeutics R&D, which affects the likelihood and timing of eventually sponsoring a registered Phase 1 trial.

Belief over time — chance it happens

0255075100Jul 1 · 71.4% chance71.4% chance
Jul 1Jul 1

Recent trades

No trades yet.